NCT00000207已完成3 期
Multicenter Clinical Trial of Buprenorphine
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Retention
研究概览
简要总结
The purpose of this study is to test the efficacy and safety of buprenorphine.
详细描述
12 different sites for a total of 736 subjects (60 at Pizarro, 70 at West LA Tx center, 15 in the 1 year extension)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •M/F, ages 21-
- •opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of the study and signed informed consent.
排除标准
- •Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
结局指标
主要结局
Retention
Opiate use
Opiate craving
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
3 期
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis PainOsteoarthritisNCT00312221Purdue Pharma LP418
终止
3 期
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back PainBack Pain Lower Back ChronicNCT00313014Purdue Pharma LP660
终止
4 期
Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)Hepatitis C, ChronicNCT00279565Indivior Inc.128
已完成
3 期
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.OsteoarthritisNCT00315848Purdue Pharma LP225
终止
3 期
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.OsteoarthritisNCT00315458Purdue Pharma LP107